Aileron Therapeutics 2024 annual meeting: re-elects directors, ratifies auditor

Rein Therapeutics, Inc.

Re-elected Brian Windsor, Ph.D. and Alan A. Musso as Class I directors (7.8M for, ~24k withheld each, 3.4M broker non-votes).
Advisory vote on named executive officer compensation passed: 7.3M for, 109k against, 416k abstain.
Ratified Marcum LLP as independent auditor for FY 2024: 10.8M for, 61k against, 416k abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.